CHICAGO RIVET & MACHINE CO financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CHICAGO RIVET & MACHINE CO files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	37	35.8	37.2	32.9	27.6	34	33.6	31.5	27	27.9
Cost of revenue	28	27.9	29.3	27.1	22.7	27.5	29.8	32.1	25.9	23.8
Gross profit	9.04	7.91	7.91	5.74	4.92	6.47	3.82	-0.6	1.06	4.13
Selling, general and administrative	5.56	5.55	5.5	5.25	5	5.11	4.99	5.24	6.22	5.66
Operating expenses						5.11	0.25	5.24	6.22	5.32
Operating income	3.48	2.37	2.4	0.49	-0.08	1.36	3.56	-5.84	-5.16	-1.2
Interest income	0.04	0.08	0.12	0.14	0.09	0.02	0.06	0.1	0.12	0.02
Other non-operating income	0.07	0.1	0.15	0.19	0.15	0.06	0.09	0.11	0.12	0.02
Pre-tax income	3.55	2.47	2.56	0.68	0.07	1.41	3.65	-5.73	-5.04	-1.18
Income tax	1.19	0.39	0.56	0.15	0.02	0.3	0.79	-1.33	0.57	-0.1
Net income	2.36	2.08	2	0.54	0.05	1.11	2.87	-4.4	-5.62	-1.08
EBITDA	4.73	3.6	3.71	1.87	1.26	2.68	4.84	-4.56	-3.99	0.02
Shares, basic (weighted)	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97
Shares, diluted (weighted)	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97
Dividend per share		1.15	1.14	1.18	0.52	0.88	0.88	0.64	0.33	0.12

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	0.35	1.15	0.71	1.43	2.57	2.04	4.05	1.39	1.92	1.72
Short-term investments							2.69	1.77	0.25	0
Receivables	5.32	5.33	5.53	4.61	5.16	5.65	4.98	4.28	3.09	3.58
Inventory	4.54	4.53	6.1	4.95	5.15	8.52	9.12	7.33	6.5	6.17
Other current assets	0.42	0.36	0.44	0.43	0.38	0.35	0.42	0.38	0.43	0.5
Total current assets	18.8	19.3	20	18	18.1	19.3	21.8	15.8	12.6	12.2
Property, plant and equipment	12.5	12.6	13.3	13.7	13.2	12.5	11.9	11.7	10.7	9.64
Lease right-of-use assets									0	0.37
Total assets	31.2	31.8	33.2	31.7	31.2	31.8	33.6	27.8	23.4	23.3
Accounts payable	0.7	0.74	1.06	0.49	0.47	0.69	0.7	0.79	1.23	0.74
Accrued liabilities	0.6	0.5	0.48	0.35	0.32	0.37	0.33	0.13	0.28	0.25
Deferred revenue								0.43	0.27	0.26
Total current liabilities	2.28	2.22	2.57	1.62	1.52	1.87	1.69	1.86	2.22	2.35
Lease liabilities									0	0.32
Other non-current liabilities								0	0.88	0.66
Total liabilities	3.31	2.96	3.49	2.57	2.53	2.8	2.64	1.86	3.34	4.47
Total debt									0
Paid-in capital	0.45	0.45	0.45	0.45	0.45	0.45	0.45	0.45	0.45	0.45
Retained earnings	30.2	31.2	32.1	31.5	31	31.3	33.3	28.3	22.4	21.2
Treasury stock	-3.92	-3.92	-3.92	-3.92	-3.92	-3.92	-3.92	-3.92	-3.92	-3.92
Shareholders' equity	27.9	28.9	29.8	29.2	28.7	29	31	26	20	18.8
Total equity	27.9	28.9	29.8	29.2	28.7	29	31	26	20	18.8
Total liabilities and equity	31.2	31.8	33.2	31.7	31.2	31.8	33.6	27.8	23.4	23.3
Shares outstanding		0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	2.36	2.08	2	0.54	0.05	1.11	2.87	-4.4	-5.62	-1.08
Depreciation and amortization	1.24	1.23	1.31	1.38	1.35	1.32	1.28	1.28	1.17	1.22
Deferred income tax	0.13	-0.29	0.18	0.02	0.07	-0.09	0.02	-1.27	0.56	-0.1
Change in receivables	-0.11	0	0.2	-0.92	0.55	0.48	-0.67	0.7	1.18	-0.48
Change in inventory	-0	-0.01	1.57	-1.15	0.2	3.37	0.6	1.79	0.83	0.33
Change in payables	-0.06	0.03	0.3	-0.57	-0.02	0.23	0	0.09	0.44	-0.49
Cash from operations	4.03	2.99	1.88	3.17	0.62	-1.01	-1.26	-1.93	-0.15	-1.23
Capital expenditures	-2.03	-1.34	-2	-1.8	-0.82	-0.67	-0.97	-1.08	-0.65	-0.33
Cash from investing	-3.52	-1.08	-1.22	-1.31	1.02	1.33	4.12	-0.11	1.01	0.64
Dividends paid	-0.96	-1.11	-1.1	-1.14	-0.5	-0.85	-0.85	-0.62	-0.32	-0.12
Cash from financing	-0.96	-1.11	-1.1	-1.14	-0.5	-0.85	-0.85	-0.62	-0.32	0.38
Net change in cash	-0.45	0.8	-0.45	0.72	1.14	-0.53	2.01	-2.66	0.54	-0.2
Free cash flow	2	1.66	-0.12	1.37	-0.2	-1.68	-2.23	-3.01	-0.8	-1.56
Interest paid									0	0.02
Income taxes paid	0.84	0.71	0.44	0.03		0.3	1.27	0	0	0.05

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $10.25 on September 24, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	11.0%	Gross profit / revenue.
Operating margin	-9.5%	Operating income / revenue.
EBITDA margin	-5.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-9.2%	Pre-tax income / revenue.
Net margin	-8.9%	Net income / revenue.
FCF margin	-5.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	-3.6%	Cash from operations / revenue.
Return on equity (ROE)	-14.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-10.3%	Net income / average total assets.
Return on invested capital (ROIC)	-12.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	20.5%	Selling, general and administrative expense / revenue.
Capex / revenue	1.6%	Capital expenditures / revenue.
D&A / revenue	4.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	3.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-6.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	0.2%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	289.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	2.6%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-3.4%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA CAGR, 3y	-83.7%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-56.0%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	-63.6%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	-48.5%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	-25.4%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-6.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-15.3%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-8.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-0.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-11.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-5.7%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.0%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.03x	Current assets / current liabilities.
Quick ratio	1.38x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.18x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	26.0%	Total liabilities / total assets.
Working capital	$8.7M	Current assets - current liabilities.
Tangible book value	$17.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.16x	Revenue / average total assets.
Fixed asset turnover	2.97x	Revenue / average property, plant and equipment.
Inventory turnover	3.85x	Cost of revenue / average inventory.
Days inventory	95 days	365 x average inventory / cost of revenue.
Receivables turnover	5.32x	Revenue / average receivables.
Days sales outstanding	69 days	365 x average receivables / revenue.
Days payables	26 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	138 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$2.53	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$28.40	Revenue / diluted weighted shares.
FCF per share	-$1.47	Free cash flow / diluted weighted shares.
Operating cash flow per share	-$1.03	Cash from operations / diluted weighted shares.
Book value per share	$18.06	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$18.06	Tangible book value / shares outstanding.
Cash per share	$0.80	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$9.9M	Share price x shares outstanding.
Enterprise value	$9.1M	Market cap + total debt - cash - short-term investments.
P/S	0.36x	Market cap / revenue.
P/B	0.57x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.57x	Market cap / tangible book value, when positive.
EV/Sales	0.33x	Enterprise value / revenue.
FCF yield	-14.3%	Free cash flow / market cap.
Earnings yield	-24.6%	Net income / market cap (the inverse of P/E).
Dividend yield	0.9%	Dividends paid over the period / market cap.
Shareholder yield	0.9%	(Dividends paid + share buybacks) / market cap.

What was CHICAGO RIVET & MACHINE CO's revenue in fiscal 2025?

CHICAGO RIVET & MACHINE CO reported revenue of $27.9M for fiscal 2025, 3.3% higher than the year before.

Was CHICAGO RIVET & MACHINE CO profitable in fiscal 2025?

No. It reported a net loss of $1.1M.

How much free cash flow did CHICAGO RIVET & MACHINE CO generate in fiscal 2025?

Cash from operations of $1.2M minus capital expenditures of $331.7K left free cash flow of -$1.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CHICAGO RIVET & MACHINE CO